RICHMOND, Calif., Feb. 21, 2017 /PRNewswire/ -- Sangamo
Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome
editing, announced today that the company will release its fourth
quarter and full year 2016 financial results before the market
opens on Tuesday, February 28, 2017.
The press release will be followed by a conference call at
8:30 a.m. ET, which will be open to
the public via telephone and webcast. During the conference call,
the company will review its financial results and provide a
business update.
The conference call dial-in numbers are (877) 377-7553 for
domestic callers and (678) 894-3968 for international callers. The
conference ID number for the call is 59818448. Participants may
access the live webcast via a link on the Sangamo Therapeutics
website in the Investors Relations section under Events and
Presentations. A conference call replay will be available for one
week following the conference call. The conference call replay
numbers for domestic and international callers are (855) 859-2056
and (404) 537-3406, respectively. The conference ID number for the
replay is 59818448.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc.
is focused on translating ground-breaking science into genomic
therapies that transform patients' lives using the company's
industry leading platform technologies in genome editing, gene
therapy, gene regulation and cell therapy. For more information
about Sangamo, visit the Company's website at www.sangamo.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-fourth-quarter-and-full-year-2016-conference-call-and-webcast-300410931.html
SOURCE Sangamo Therapeutics, Inc.